26 related articles for article (PubMed ID: 38626490)
1. Utility of sulfachloropyridazine in the synthesis of novel anticancer agents as antiangiogenic and apoptotic inducers.
Zahran SS; Ragab FA; Soliman AM; El-Gazzar MG; Mahmoud WR; Ghorab MM
Bioorg Chem; 2024 Jul; 148():107411. PubMed ID: 38733747
[TBL] [Abstract][Full Text] [Related]
2. New benzimidazole-oxadiazole derivatives as potent VEGFR-2 inhibitors: Synthesis, anticancer evaluation, and docking study.
Acar Çevik U; Celik I; Görgülü Ş; Şahin Inan ZD; Bostancı HE; Özkay Y; Kaplacıklı ZA
Drug Dev Res; 2024 Jun; 85(4):e22218. PubMed ID: 38825827
[TBL] [Abstract][Full Text] [Related]
3. Anti-proliferative, Morphological and Molecular Docking Studies of New Thiophene Derivatives and their Strategy in Ionic Liquids Immobilized Reactions.
Mohareb RM; Mukhtar S; Parveen H; Abdelaziz MA; Alwan ES
Anticancer Agents Med Chem; 2024; 24(9):691-708. PubMed ID: 38321904
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and ex vivo anti-drug resistant cervical cancer activity of novel molecularly targeted chalcone derivatives.
Yang Z; Wang Y; Ablise M; Maimaiti A; Mutalipu Z; Yan T; Liu ZY; Aihaiti A
Bioorg Chem; 2024 Aug; 149():107498. PubMed ID: 38805911
[TBL] [Abstract][Full Text] [Related]
5. Novel angiogenesis inhibitors with superoxide anion radical amplification effect: Surmounting the Achilles' heels of angiogenesis inhibitors and photosensitizers.
Wang K; Liu J; Hai P; Zhang W; Shan Y; Zhang J
Eur J Med Chem; 2024 Jun; 272():116495. PubMed ID: 38744089
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of novel indol-3-acetamido analogues as potent anticancer agents, biological evaluation and molecular modeling studies.
Doganc F; Ozkan T; Farhangzad N; Mavideniz A; Celik I; Sunguroglu A; Göker H
Bioorg Chem; 2024 Jul; 148():107429. PubMed ID: 38728910
[TBL] [Abstract][Full Text] [Related]
7. New Thieno[2,3-d]pyrimidines as Anticancer VEGFR-2 Inhibitors with Apoptosis Induction: Design, Synthesis, and Biological and In Silico Studies.
Sobh EA; Dahab M; Elkaeed E; Alsfouk B; Ibrahim I; Metwaly AM; Eissa I
Med Chem; 2024 May; ():. PubMed ID: 38798211
[TBL] [Abstract][Full Text] [Related]
8. Development and assessment of novel pyrazole-thiadiazol hybrid derivatives as VEGFR-2 inhibitors: design, synthesis, anticancer activity evaluation, molecular docking, and molecular dynamics simulation.
Halimi G; Osmaniye D; Özkay Y; Kaplancıklı ZA
Z Naturforsch C J Biosci; 2024 Jun; ():. PubMed ID: 38818683
[TBL] [Abstract][Full Text] [Related]
9. Recent advances and future directions on small molecule VEGFR inhibitors in oncological conditions.
Thakur A; Rana M; Mishra A; Kaur C; Pan CH; Nepali K
Eur J Med Chem; 2024 Jun; 272():116472. PubMed ID: 38728867
[TBL] [Abstract][Full Text] [Related]
10. Innovative Fusion: Natural Compound-Rhein and PROTACs Unleash Potent VEGFR-2 Degraders.
Liu J; Zhang Z; Xu M; Shi R; He X; Wang Y; Shao Y; Huang C; Zhang F; Zhang P
Chem Biodivers; 2024 May; ():e202400753. PubMed ID: 38818648
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and in vitro and in vivo anti-angiogenesis study of a novel vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitor based on 1,2,3-triazole scaffold.
Wang DP; Liu KL; Li XY; Lu GQ; Xue WH; Qian XH; Mohamed O K; Meng FH
Eur J Med Chem; 2021 Feb; 211():113083. PubMed ID: 33340911
[TBL] [Abstract][Full Text] [Related]
12. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
13. Novel benzothiazole-based dual VEGFR-2/EGFR inhibitors targeting breast and liver cancers: Synthesis, cytotoxic activity, QSAR and molecular docking studies.
Abd El-Meguid EA; Naglah AM; Moustafa GO; Awad HM; El Kerdawy AM
Bioorg Med Chem Lett; 2022 Feb; 58():128529. PubMed ID: 35007724
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel thiophene-3-carboxamide derivatives as potential VEGFR-2 inhibitors with anti-angiogenic properties.
Li T; Wang J; Feng L; Zhou Q; Xie Q; Shen Y; Ji R; Liu X; Wang Y; Hu C
Bioorg Chem; 2024 Jun; 147():107358. PubMed ID: 38626490
[TBL] [Abstract][Full Text] [Related]
15. Design, Molecular Modeling, MD Simulations, Essential Dynamics, ADMET, DFT, Synthesis, Anti-proliferative, and Apoptotic Evaluations of a New Anti-VEGFR-2 Nicotinamide Analogue.
Eissa IH; Elkaeed EB; Elkady H; Yousef RG; Alsfouk BA; Elzahabi HSA; Ibrahim IM; Metwaly AM; Husein DZ
Curr Pharm Des; 2023; 29(36):2902-2920. PubMed ID: 38031271
[TBL] [Abstract][Full Text] [Related]
16. Discovery of New Quinazoline Derivatives as VEGFR-2 Inhibitors: Design, Synthesis, and Anti-proliferative Studies.
Dhawale SA; Dabhade PS; Mokale SN
Anticancer Agents Med Chem; 2023; 23(18):2042-2055. PubMed ID: 37455449
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
